ChemoCentryx, Inc. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-05-28: Reporting owner KLEIN IRA; Form 3; Security No securities are beneficially owned; Transaction Holding.
- 2012-11-20: Reporting owner Bekker Petrus; Form 4; Security Employee Stock Optin; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-06-07: Reporting owner Tyree James L; Form 3; Security No securities are beneficially owned; Transaction Holding.
- 2012-04-27: Reporting owner FECZKO JOSEPH M; Form 3; Security No securities are beneficially owned; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-05-28 holding as of filing | KLEIN IRA Director | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2013-05-28 | |
| 2012-11-20 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Optin Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,439 47,500 owned after | $0.60 exercise price | 2012-11-20 | |
| 2012-06-07 holding as of filing | Tyree James L Director | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2012-06-07 | |
| 2012-04-27 holding as of filing | FECZKO JOSEPH M Director | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2012-04-27 |